Latest news with #TheCloroxCompany
Yahoo
12-05-2025
- Business
- Yahoo
Clorox Announces Election of Gina Boswell to its Board of Directors
OAKLAND, Calif., May 12, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced the election of Gina Boswell to its board of directors, effective May 19, 2025. Boswell, 62, is the chief executive officer of Bath & Body Works, Inc., and also serves on its board. Her extensive leadership and operational experience also includes prior senior roles with Unilever, Avon, Ford and Estée Lauder. Boswell's deep consumer goods sector background across retail, marketing, brand building, business development, operations and innovation enables her to provide valuable perspective on Clorox's business strategy and growth. Boswell also has extensive public company board experience, having previously served on the boards of ACCO Brands Corporation, Manpower Group, Inc., and Wolverine Worldwide, Inc. "Gina's exceptional consumer experience is a tremendous asset to Clorox, and we are honored to have her on our board," said Linda Rendle, chair and chief executive officer of The Clorox Company. "Her global expertise in driving growth and innovation will serve us well as we deliver superior value for our consumers and consistent, profitable growth for our shareholders." Boswell's appointment will bring the number of Clorox board members to 12. Additional information about The Clorox Company board of directors can be found at About The Clorox CompanyThe Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate ESG into its business reporting. In 2025 the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year. Visit to learn more. CLX-F View original content to download multimedia: SOURCE The Clorox Company
Yahoo
25-04-2025
- Business
- Yahoo
The Clorox Company (CLX): Among the Growing Dividend Stocks with Low PE Ratios
We recently published a list of the . In this article, we are going to take a look at where The Clorox Company (NYSE:CLX) stands against other growing dividend stocks. Value stocks are enjoying a rare period of strength amid this year's broader market downturn. With earnings season approaching, it remains to be seen whether their recent edge over high-growth stocks will hold. The S&P Value Index—which includes sectors like banking, consumer staples, and healthcare, featuring companies that trade at relatively low valuations—has fallen around 9% this year. That's a smaller drop compared to the more than 15% decline seen in the growth-focused counterpart. Concerns over steep valuations in the tech sector, coupled with a wave of risk aversion triggered by tariffs, have pushed investors to shift from growth to value. While similar shifts haven't lasted long in the past, some investors believe that this time could be different, as expectations for value-oriented firms are modest enough that they may exceed them when earnings reports begin next month. Dan Morgan, senior portfolio manager at Synovus Trust, made the following comment about value investing: 'The bar has been set pretty low for value stocks compared to the uncertainty surrounding growth names and their ability to deliver on earnings estimates. If value can at least match or slightly beat expectations, the runway is clear for them.' According to data from Bloomberg Intelligence, analysts are forecasting a 12% decline in first-quarter earnings for value companies compared to the same period last year, while growth companies are expected to post a 20% increase. Supporters of value stocks believe that these lower expectations are already factored into their relatively modest valuations. On the other hand, optimism surrounding growth stocks—particularly in the tech sector—has soared in recent years, largely driven by enthusiasm over advancements in artificial intelligence. Historically, value stocks have lagged behind. Over the past 20 years, the S&P 500 Value Index has only outperformed its growth counterpart five times on an annual basis. During that period, the value index climbed 202%, while the growth index surged by 600%. Michael O'Rourke, chief market strategist at JonesTrading Institutional Services, made the following statement: 'Growth is about 40% more expensive; this outperformance of value was very long overdue. Due to the incredible strength of the Magnificent Seven, too many investors crowded into growth thinking it won't correct.' Investors often turn to dividend stocks when looking at companies with lower valuations. Dan Lefkovitz, a strategist at Morningstar Indexes, pointed out that dividend-growth stocks—those known for consistently raising their payouts—have underperformed the broader market in 2024. He attributed this to a market that has largely been driven by a handful of fast-growing tech names. However, he also remarked that while dividend-paying stocks may trail during such growth-led rallies, they tend to hold up better during market downturns, as seen in 2022 and 2018. Companies that consistently raise their dividends are often both profitable and financially stable—traits that become especially important during times of economic downturn. A team of professionals prepping for a training seminar, using professional cleaning products produced by the company. For this list, we focused on dividend-paying companies that have consistently paid dividends over the years and have also demonstrated a track record of increasing their payouts. From that group, we considered stocks with forward P/E ratios below 25, as of April 22. The stocks are ranked in ascending order of their P/E ratios. At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). Forward P/E Ratio as of April 22: 18.76 The Clorox Company (NYSE:CLX) is an American company that specializes in the manufacturing and marketing of consumer and professional products. The company's strong market position is closely tied to its close partnerships with major retailers. Walmart alone makes up about 25% of the company's sales, and the top five customers collectively generate nearly half of its total revenue. Although this level of customer concentration could be viewed as a potential risk, it actually gives Clorox significant bargaining power. These relationships help the company gain premium shelf space, run cross-brand promotions, and collaborate on marketing efforts—advantages that are difficult for rivals to replicate. In fiscal Q2 2025, The Clorox Company (NYSE:CLX) reported revenue of $1.7 billion, which fell by 15.2% from the same period last year. However, the revenue beat analysts' estimates by $60 million. Gross margin rose by 30 basis points, reaching 43.8% compared to 43.5% in the same quarter last year. This improvement was mainly due to cost-saving initiatives and the positive impact of selling off the VMS and Argentina operations. However, these gains were somewhat offset by lower cost absorption and increased expenses related to manufacturing, logistics, and raw materials. The Clorox Company (NYSE:CLX)'s cash position remained strong. Year-to-date, the company generated $401 million in operating cash flow, which showed 132% growth from the prior-year period. The company currently offers a quarterly dividend of $1.22 per share and has a dividend yield of 3.44%, as of April 22. It has been growing its dividends for 22 consecutive years. Overall, CLX ranks 23rd on our list of the best growing dividend stocks with low P/E ratios. While we acknowledge the potential of CLX as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for a deeply undervalued dividend stock that is more promising than CLX but that trades at 10 times its earnings and grows its earnings at double digit rates annually, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at .
Yahoo
09-04-2025
- Business
- Yahoo
Investors five-year losses continue as Clorox (NYSE:CLX) dips a further 7.8% this week, earnings continue to decline
The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results between individual stocks. At this point some shareholders may be questioning their investment in The Clorox Company (NYSE:CLX), since the last five years saw the share price fall 30%. The falls have accelerated recently, with the share price down 15% in the last three months. But this could be related to the weak market, which is down 17% in the same period. If the past week is anything to go by, investor sentiment for Clorox isn't positive, so let's see if there's a mismatch between fundamentals and the share price. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). Looking back five years, both Clorox's share price and EPS declined; the latter at a rate of 10% per year. The share price decline of 7% per year isn't as bad as the EPS decline. The relatively muted share price reaction might be because the market expects the business to turn around. You can see below how EPS has changed over time (discover the exact values by clicking on the image). We know that Clorox has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Clorox will grow revenue in the future. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Clorox, it has a TSR of -19% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return. Although it hurts that Clorox returned a loss of 2.2% in the last twelve months, the broader market was actually worse, returning a loss of 4.5%. What is more upsetting is the 4% per annum loss investors have suffered over the last half decade. This sort of share price action isn't particularly encouraging, but at least the losses are slowing. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 3 warning signs for Clorox you should know about. But note: Clorox may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
30-03-2025
- Business
- Yahoo
Is Clorox Company (CLX) the Best Consumer Staples Stock to Buy According to Analysts?
We recently published a list of . In this article, we are going to take a look at where The Clorox Company (NYSE:CLX) stands against other best consumer staples stocks to buy according to analysts. Consumer confidence is plunging in the US. It dropped further in March, with the Conference Board reporting the future outlook falling to the lowest level in more than a decade. The Conference Board's monthly confidence index dropped to 92.9, reflecting a 7.2-point slip and making March the fourth consecutive month of index contraction. The index calculates respondents' outlook on job prospects, business, and income. The fall was higher than analyst estimates, as economists surveyed by Dow Jones estimated a reading of 93.5. That is not all: the measure for future estimates is painting an even bleaker story with the index falling to 65.2, reflecting a 9.6-point drop and making it the lowest number in 12 years. The reading is also considerably below the 80 level, which is typically considered a benchmark signal for an incoming recession. While the confidence drop was spread across income groups, it was primarily driven by a decline in consumers aged 55 or older. These readings are materializing at a time uncertainty and concerns regarding President Trump's tariffs are already looming on the market. These concerns have coincided with other surveys exhibiting waning consumer sentiment and a volatile stock market. CNBC reported that Stephanie Guichard, senior economist, global indicators at The Conference Board, said the following about the situation: 'Consumers' optimism about future income — which had held up quite strongly in the past few months — largely vanished, suggesting worries about the economy and labor market have started to spread into consumers' assessments of their personal situations.' On March 14, CNBC reported that while headwinds like persistent inflation and high interest rates were already affecting companies, they now have to deal with additional obstacles such as worsening consumer sentiment, tariffs that go on and off, and mass government layoffs. Over the last weeks, investor presentations and earnings calls have shown a distinct trend: consumer-facing businesses and retailers are warning that fiscal Q1 2025 sales are coming in softer than expected. 2025 may prove to be a year tougher than what analysts initially estimated. READ ALSO: and . Consumer staples are generally considered a safe haven amid recession and market volatility. We discussed how the consumer staple sector is expected to perform and whether it can be considered a safety net amid the current market dynamics in a recently published article on . Here is an excerpt from the article to shed light on the situation: 'On March 21, Bryan Spillane, Bank of America Securities' senior food and beverage analyst, appeared on CNBC's 'The Exchange' to discuss things across his space and the trends surrounding consumer staples. He said that going through the first quarter of the year and having check-ins with companies has led him to conclude that the conditions in the sector have been soft, which is true across his entire coverage universe. Consumers are pulling back a bit, and there's uncertainty surrounding the conditions in the sector. What's surprising is that these trends started in January and extended through the first quarter. We sifted through stock screeners, financial media reports, and ETFs to compile a list of 40 consumer staple stocks popular among hedge funds and selected the top 10 with the highest analyst upside potential as of March 28, 2025. We also added the number of hedge fund holders for each stock, as of Q4 2024. The list is ordered in ascending order of analyst upside potential. We sourced the hedge fund sentiment data from Insider Monkey's database. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A team of professionals prepping for a training seminar, using professional cleaning products produced by the company. Analyst Upside: 15.40% Number of Hedge Fund Holders: 54 The Clorox Company (NYSE:CLX) is a multinational marketer and professional and consumer goods manufacturer. It operates through four segments: Household, Health and Wellness, Lifestyle, and International. The Health and Wellness segment comprises cleaning, disinfecting, and professional products sold and marketed under various brands. The company's International segment comprises products sold outside the US, and includes products such as laundry additives, home care products, and more. The Clorox Company (NYSE:CLX) expects increased advertising in H2 2025 compared to H1. This aggressive promotion and advertising spending, even during a period of increased expenses, reflects the company's confidence in its new product launches and robust brand portfolio. The company has a 3.3% dividend yield and has had 40 consecutive years of dividend raises. By investing in top brands, The Clorox Company (NYSE:CLX) has been focused on margin improvement instead of revenue growth. Fiscal Q2 2025 marked the ninth consecutive quarter of gross margin expansion for the company. For the full fiscal year, it is anticipating organic sales growth of around 3% to 5% and gross margin expansion of 125 to 150 basis points. The company takes the fifth spot on our list of the best consumer staples stocks to buy according to analysts. Overall, CLX ranks 5th on our list of best consumer staples stocks to buy according to analysts. While we acknowledge the potential of CLX, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CLX but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: and . Disclosure: None. This article is originally published at . Sign in to access your portfolio
Yahoo
01-03-2025
- Business
- Yahoo
Jim Cramer Says The Clorox Company (CLX) ‘Might Make For A Good Investment'
We recently published a list of . In this article, we are going to take a look at where The Clorox Company (NYSE:CLX) stands against other stocks that Jim Cramer discussed. Jim Cramer, the host of Mad Money, on Thursday, shared his thoughts on the market's volatility following President Donald Trump's tariff announcements and provided insights into which sectors and stocks could weather the impact of these new trade policies. READ ALSO: Jim Cramer Thoughts on 8 Stocks As He Discussed Market Froth and Jim Cramer Shed Light on These 10 Stocks 'President Trump is out there fighting inflation every day except not the way we want him to do it. He's fighting inflation, not in the mall, not in the supermarket, but in the stock market. He pointed out that Trump is attempting to reduce prices in the market by gradually bringing down stock values, noting that if the current trend continues, we may eventually see stock prices return to pre-COVID levels. Cramer also identified stocks he believes could be relatively insulated from the negative effects of these tariffs. He emphasized that these are the companies whose values are not directly impacted by the primary reason many stocks are struggling, tariffs. The protected stocks, according to Cramer, can maintain their worth even if additional tariffs are imposed on other countries. Cramer's list was aimed at those seeking stability in an uncertain market environment, where the next country to be hit with tariffs remains unclear. He went on to say: 'Starting with tech first. Nothing that can be sold to China has a chance to get out of this thing unscathed. Nothing that has parts made in Taiwan can hold its value. Nothing that's crafted in China can stay up. If we can't be sure where the next tariff is gonna land, we can't own these stocks until they go lower and then we can.' Turning to the transportation sector, Cramer was blunt in his assessment. He pointed out that transportation stocks are closely tied to global commerce, which in turn is directly affected by tariffs. With tariffs raising the cost of goods, Cramer argued, global trade will slow, which will negatively impact businesses across the board. He highlighted the general economic principle that raising prices leads to reduced sales, making the transportation sector vulnerable to these market shifts. When it came to the auto industry, Cramer described the situation as a tough one. For this article, we compiled a list of 13 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on February 27. We listed the stocks in the order that Cramer mentioned them. We also provided hedge fund sentiment for each stock as of the fourth quarter of 2024, which was taken from Insider Monkey's database of over 1,000 hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A team of professionals prepping for a training seminar, using professional cleaning products produced by the company. Number of Hedge Fund Holders: 54 Unlike other consumer packaged goods plays, Cramer noted that The Clorox Company (NYSE:CLX) is perhaps immune to tariffs as he said: 'How about consumer packaged goods? The makers of these products, long ago, they decided the real money was overseas. They couldn't make enough money here. We'd have to find one that didn't diversify internationally perhaps because it didn't know how to do it. Maybe that makes it immune now. That's Clorox… Might make for a good investment.' Clorox (NYSE:CLX) produces and sells a wide range of consumer and professional products, spanning categories such as cleaning, disinfecting, household goods, personal care, food, and health supplements. In January, Cramer said: 'The dollar's gotten too strong. These consumer packaged goods companies tend to be very big overseas. That's not the case with Clorox, which is largely domestic. But you know how our stock market works. The consumer staples all trade together. If the dollar hurts a big international company like Procter & Gamble as it is, it's gonna reverberate even into Clorox because they're all in the same sector, and sector ETFs are like gravity.' Overall, CLX ranks 3rd on our list of stocks that Jim Cramer discussed. While we acknowledge the potential of CLX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CLX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
